Trials / Unknown
UnknownNCT04190966
Smoking Cessation in the Surgical Pathway Before Major Lung Surgery
A Trial to Study the Effectiveness of Smoking Cessation in the Surgical Pathway Before Major Lung Surgery: Project MURRAY Feasibility Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- University of Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a feasibility study of a personalised, integrated smoking cessation in the surgical pathway in patients undergoing major elective thoracic surgery when compared to usual care of standard community/hospital based NHS smoking cessation. Half the patients will receive the intervention and half the patients will receive usual care.
Detailed description
Smoking prior to major thoracic surgery is a major risk factor for development of postoperative complications which effect both short and long-term outcome. Despite this 1 in 5 patients continue to smoke before their operation. Project MURRAY is a trial comparing the effectiveness of personalised integrated smoking cessation delivered by trained health-care practitioners in the thoracic surgical pathway, and is a three part package of behaviour interventions and pharmacotherapy as per National Institute of Clinical Excellence (NICE)/ National Centre for Smoking Cessation Training (NCSCT) guidance which is supported by an adjunct web-based application. This is a pilot study to evaluate feasibility of a substantive trial and study processes in 5 adult thoracic centres including the trial coordinating site at the University Hospitals Birmingham NHS Foundation Trust. This is a multicentre feasibility study, with aim for equal weighting between the two arms of the integrated smoking cessation and an observation only group of usual care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Integrated Behavioural therapy | Integrated smoking cessation behavioural therapy |
| DRUG | Integrated Pharmacotherapy | Integrated smoking cessation pharmacotherapy including choice of combination nicotine replacement therapy, varenicline or electronic cigarettes |
| DEVICE | Integrated Web-based application | Integrated smoking cessation web-based application |
Timeline
- Start date
- 2020-01-31
- Primary completion
- 2021-07-31
- Completion
- 2021-12-31
- First posted
- 2019-12-09
- Last updated
- 2020-01-06
Source: ClinicalTrials.gov record NCT04190966. Inclusion in this directory is not an endorsement.